HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Chuan Tai Selected Research

Cyclophosphamide (Cytoxan)

11/2012Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Chuan Tai Research Topics

Disease

2Lymphoma (Lymphomas)
01/2021 - 02/2013
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2013 - 11/2012
1Infections
03/2009
1Metrorrhagia (Spotting)
07/2003

Drug/Important Bio-Agent (IBA)

2Rituximab (Mabthera)FDA Link
02/2013 - 11/2012
1ParaffinIBA
01/2021
1Formaldehyde (Formol)FDA Link
01/2021
1Proteins (Proteins, Gene)FDA Link
02/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2012
1Vincristine (Oncovin)FDA LinkGeneric
11/2012
1Prednisone (Sone)FDA LinkGeneric
11/2012
1isochorismic acid (isochorismate)IBA
03/2009
1Oligonucleotide ProbesIBA
07/2003
1DNA (Deoxyribonucleic Acid)IBA
07/2003

Therapy/Procedure

1Therapeutics
11/2012